

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
JNJ | NYSE | USD | Real-time | |
JNJ | Mexico | MXN | Delayed | |
JNJ | TradeGate | EUR | Delayed | |
JNJ | Frankfurt | EUR | Delayed | |
JNJ | Xetra | EUR | Delayed | |
JNJ | Buenos Aires | ARS | Delayed | |
DJNJ2 | Buenos Aires | ARS | Delayed | |
JNJB34 | BM&FBovespa | BRL | Delayed | |
JNJ | Vienna | EUR | Delayed | |
JNJ_KZ | KASE | USD | Delayed | |
JNJ | Colombia | COP | Delayed | |
JNJ | Lima | USD | Delayed |
(Reuters) - Emergent BioSolutions Inc said on Friday it had received a warning letter from the U.S. Food and Drug Administration, citing certain deficiencies at the contract drugmaker's manufacturing...
(Reuters) - Emergent BioSolutions Inc said on Friday it had received a warning letter from the U.S. Food and Drug Administration, citing certain deficiencies at the contract drugmaker's manufacturing...
(Reuters) - Johnson & Johnson (NYSE:JNJ) will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales of a product that...
By Marisa Taylor and Mike Spector WASHINGTON (Reuters) - The U.S. Justice Department has opened a criminal investigation into Cassava Sciences (NASDAQ:SAVA) Inc involving whether the biotech company...
By David Randall NEW YORK (Reuters) - Companies reporting earnings in coming weeks are likely to mention one common factor gouging their results: the strong dollar. The U.S. currency stands near a...
(The story corrects paragraph three to say company reported Q2, not Q1, results) By Manas Mishra (Reuters) - Johnson & Johnson (NYSE:JNJ) on Tuesday reported quarterly results that beat analysts'...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review